Medicines, elevated
Treeline Biosciences is a clinical-stage biopharma developing precision medicines for cancer, autoimmune, and neurological diseases. The company integrates in-house biology, chemistry, protein science, and computational/ML tools to advance a pipeline of inhibitors, protein degraders, and antibody drug conjugates through human clinical trials.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountSep 2025
Oct 2024
Aug 2024
Jan 2021
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Biotech venture firm and therapeutics accelerator that invests at seed stage and acts as a drug d...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
